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Abstract
Background: Primary diagnostic cultures from patients with melioidosis demonstrate variation in colony
morphology of the causative organism, Burkholderia pseudomallei. Variable morphology is associated with changes
in the expression of a range of putative virulence factors. This study investigated the effect of B. pseudomallei
colony variation on survival in the human macrophage cell line U937 and under laboratory conditions simulating
conditions within the macrophage milieu. Isogenic colony morphology types II and III were generated from 5
parental type I B. pseudomallei isolates using nutritional limitation. Survival of types II and III were compared with
type I for all assays.
Results: Morphotype was associated with survival in the presence of H2O2 and antimicrobial peptide LL-37, but
not with susceptibility to acid, acidified sodium nitrite, or resistance to lysozyme, lactoferrin, human neutrophil
peptide-1 or human beta defensin-2. Incubation under anaerobic conditions was a strong driver for switching of
type III to an alternative morphotype. Differences were noted in the survival and replication of the three types
following uptake by human macrophages, but marked strain-to strain-variability was observed. Uptake of type III
alone was associated with colony morphology switching.
Conclusions: Morphotype is associated with phenotypes that alter the ability of B. pseudomallei to survive in
adverse environmental conditions.
Background
Burkholderia pseudomallei is an environmental Gram-
negative bacterium that causes a severe and often fatal
disease called melioidosis. This is an important cause of
sepsis in south-east Asia and northern Australia, a geo-
graphic distribution that mirrors the presence of
B. pseudomallei in the environment [1]. Melioidosis may
develop following bacterial inoculation or inhalation and
occurs most often in people with regular contact with
contaminated soil and water [1]. Clinical manifestations
of melioidosis are highly variable and range from fulmi-
nant septicemia to mild localized infection. The overall
mortality rate is 40% in northeast Thailand (rising to
90% in patients with severe sepsis) and 20% in northern
Australia [1,2].
A major feature of melioidosis is that bacterial eradica-
tion is difficult to achieve. Fever clearance time is often
prolonged (median 8 days), antimicrobial therapy is
required for 12-20 weeks, and relapse occurs in around
10% of patients despite an appropriate course of antimi-
crobial therapy [3,4]. The basis for persistence in the
infected human host is unknown, although several obser-
vations made to date may be relevant to the clinical beha-
viour of this organism [2,5]. B. pseudomallei can resist the
action of bactericidal substances including complement
and antimicrobial peptides in human serum [6-8]. B. pseu-
domallei can also survive after uptake by a range of phago-
cytic and non-phagocytic cells. Macrophages have several
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strategies to control bacterial infection, including bacterial
killing following uptake through the action of reactive
oxygen and reactive nitrogen compounds, antimicrobial
peptides and lysozomal enzymes. Despite this, B. pseudo-
mallei can invade and replicate in primary human macro-
phages [8-10].
Bacterial survival under adverse and rapidly changing
environmental conditions is likely to be facilitated by pheno-
typic adaptability and plasticity. A previous study conducted
by us found that 8% of primary cultures of clinical samples
taken from patients with melioidosis contained more than
one colony morphotype on Ashdown agar. Morphotypes
could switch reversibly from one to another under specific
conditions, and were associated with variable expression of
putative virulence determinants including biofilm and fla-
gella [11]. Compared with parental type I (the common
‘cornflower head’ morphology), isogenic type II (a small,
rough colony) had increased biofilm and protease produc-
tion, while isogenic type III (a large, smooth colony) was
associated with increased flagella expression [11]. In vitro
models suggested that switching of morphotype impacted
on intracellular replication fitness after uptake by human
epithelial cell line A549 and mouse macrophage cell line
J774A.1. We postulated that colony morphology switching
might represent a mechanism by which B. pseudomallei can
adapt within the macrophage and persist in vivo.
In this study, we investigated whether the variable
phenotype associated with different morphotypes
resulted in altered fitness during interactions with the
human macrophage cell line U937 and after exposure to
a range of laboratory conditions that simulate one or
more conditions within the macrophage milieu. Isogenic
morphotypes II and III generated from each parental
type I of 5 B. pseudomallei strains isolated from patients
or soil were used in all experiments.
Results
Growth curve analysis of isogenic morphotypes
Different growth rates may affect the number of intracellu-
lar bacteria following uptake by host cells. Thus, prior to
observation of intracellular replication in macrophages,
extracellular growth of B. pseudomallei was compared
between 3 isogenic morphotypes cultured in trypticase soy
broth (TSB). Using a starting inoculum of 1 × 104 CFU/
ml, log and stationary phase occurred at 2 h and 12 h,
respectively, for all 3 morphotypes. There was no differ-
ence in doubling time between 3 isogenic morphotypes
(P = 0.14) with an average doubling time of 40.2, 39.2 and
38.3 minutes for types I, II and III, respectively.
Replication of isogenic B. pseudomallei morphotypes in
macrophages
Evaluation of the initial B. pseudomallei-macrophage cell
interaction using a multiplicity of infection (MOI) of
25:1 demonstrated that 3.0% of the bacterial inoculum
(range 1.2-8.0% for different isolates) was associated
with macrophages at 2 h. There was no significant dif-
ference in this value between 3 isogenic morphotypes
for all 5 isolates.
Following removal of extracellular bacteria and incu-
bation for a further 2 h, 1.5% of the bacterial inoculum
(range 0.4-3.4% for different isolates) was recovered.
There was no significant difference in this value between
3 isogenic morphotypes for all 5 isolates.
The intracellular replication of B. pseudomallei
between 4 to 8 h within macrophages is summarized in
Figure 1. The replication rates for the 3 isogenic mor-
photypes of each strain obtained from two independent
experiments were comparable (data not shown). Percent
replication at 8 h was defined in relation to the 4 h time
point, which was used as the reference count. Analysis
of pooled data for 5 isolates demonstrated that type I
had a significantly higher rate of intracellular replication
than either type II or III. The mean intracellular replica-
tion of type I at 8 h was 2.0 (95%CI 1.5-2.6, P = 0.004)
times higher than that of type II, and 1.9 (95%CI 1.4-
2.5, P = 0.004) times higher than that of type III (Figure
1A). However, this pattern was not uniformly observed
for each of the 5 isolates, as shown in Figure 1B-F. The
higher replication fitness for type I based on the sum-
mary data was largely accounted for strains 164 and
K96243. Other strains demonstrated a different pattern.
For example, strain 153 type III had a higher intracellu-
lar replication than type I, a finding that replicates those
of a previous study [11]. The mean intracellular bacterial
count also varied between individual isolates. These dif-
ferences were not due to the relative sensitivities of 3
isogenic morphotypes to 250 μg/ml kanamycin, as this
experimental condition removed 99.9% of extracellular
bacteria independent of type for all isolates (data not
shown).
Susceptibility of isogenic morphotypes to acid
To examine the effect of acid, growth of 3 isogenic mor-
photypes in LB at pH 4.0, 4.5, 5.0 and 7.0 was compared
at each of 5 time points over 24 h of incubation. No
growth difference was observed between morphotypes at
any time point for pH 4.5, 5.0 or 7.0 (P > 0.10 for all
time points). When cultured in LB broth at pH 4.0, all
bacteria died within 12 h incubation.
Susceptibility of isogenic morphotypes to reactive oxygen
intermediates (ROI)
The susceptibility of 3 morphotypes to ROI was initi-
ally examined on LB agar plates containing a range of
H2O2 concentrations (0, 170, 310, 625, 1,250 and 2,500
μM) (data not shown). B. pseudomallei failed to grow
on plates with H2O2 at a concentration higher than
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Figure 1 Intracellular replication of 3 isogenic morphotypes of B. pseudomallei in human macrophages. Differentiated U937 cells were
incubated for 2 h with B. pseudomallei at a MOI of 25:1, after which non-adherent bacteria were removed by washing and incubation for a
further 2 h with kanamycin. At this 4 h time point, fresh medium containing kanamycin was added and incubation continued for a further 4 h.
The bacterial count and colony morphology were enumerated at 4, 6 and 8 h by cell lysis and plating onto Ashdown agar. The data shown in
Figure 1A represent mean values for each isogenic morphotype derived from 5 B. pseudomallei isolates and is expressed as the bacterial
proportion at 6 and 8 h compared with the number at 4 h (which was defined as 100%). Figure 1B-1F shows the number of intracellular
bacteria in CFU/ml for individual isolates. Data plots are means ± standard deviations.
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625 μM, and so the percentage of viable bacteria were
enumerated using agar plates with 625 μM H2O2 com-
pared to those on plates without H2O2. This demon-
strated a difference in bacterial survival between the
three isogenic morphotypes (P < 0.001). Percentage
survival of type I was 3.8 (95%CI 2.9-5.0, P < 0.001)
times higher than that for type II, and was 5.2 (95%CI
4.0-6.8, P < 0.001) times higher than that for type III
(Figure 2A).
Further examination was undertaken of the susceptibil-
ity of the 3 morphotypes with a range of concentrations
of H2O2 in LB broth. No bacteria survived in 500 μM
and 250 μM H2O2. In 125 μM H2O2, type I of all 5 iso-
lates multiplied from 1 × 106 CFU/ml (the starting inocu-
lum) to between 5 × 107 and 2.1 × 108 CFU/ml. By
contrast, all 5 type III and 4 type II isolates (the exception
being type II derived from isolate 164) obtained from the
same experiment demonstrated no growth on the plates.
This confirmed a higher resistance to H2O2 of parental
type I compared to types II and III. A difference was also
observed between three isogenic morphotypes in
62.5 μM H2O2 (P < 0.001). Bacterial growth of type I was
1.5 (95%CI 1.1-2.0, P = 0.02) times higher than that for
type II, and was 2.7 (95%CI 2.0-3.7, P < 0.001) times
higher than that for type III.
Susceptibility of isogenic morphotypes to reactive
nitrogen intermediates (RNI)
Susceptibility of B. pseudomallei to RNI was observed
following 6 h exposure to various concentrations of
NaNO2 ranging between 0.1 to 10 mM in acidified pH
5.0 in LB broth. Using a concentration of 2 mM
NaNO2, the percent survival of types I, II and III
were 43.8%, 43.7% and 40.1%, respectively, with no
difference observed between the three morphotypes
(P > 0.10).
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Figure 2 Susceptibility of 3 isogenic morphotypes of B. pseudomallei to ROI and antimicrobial peptide LL-37. Survival was examined for
5 different B. pseudomallei isolates. (A) Percent survival in ROI was determined on LB agar plates containing 625 μM H2O2 compared to the
number of bacteria on plates without H2O2. The results were obtained from 4 separate experiments. (B) Percent survival in LL-37 was determined
at 6.25 μM LL-37 in 1 mM potassium phosphate buffer (PPB) pH 7.4 for 6 h. The results were obtained from 2 separated experiments. Data plots
are means ± standard deviations.
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Susceptibility of isogenic morphotypes to lysozyme and
lactoferrin
Compared with initial inocula and untreated controls,
treatment with 200 μg/ml lysozyme at pH 5.0 did not
decrease the bacterial count for the 3 isogenic morpho-
types of B. pseudomallei, while this concentration could
reduce the number of E. coli from 4.9 × 106 CFU/ml
(the starting inoculum) to 425 CFU/ml. Susceptibility
was examined further in the presence of 3 mg/ml lacto-
ferrin. A kinetic study over time demonstrated that lac-
toferrin alone could kill an entire E. coli inoculum of
1 × 106 CFU/ml within 3 h at pH 5.0. The same treat-
ment did not affect the number of viable B. pseudomal-
lei which was comparable to the inoculum and
untreated control. Adding 200 μg/ml lysozyme with lac-
toferrin did not enhance the killing efficacy of E. coli
and had no effect on B. pseudomallei.
Susceptibility of isogenic morphotypes to antimicrobial
peptides
Macrophages produce several antimicrobial peptides
[12,13]. We examined the susceptibility of isogenic mor-
photypes to HNP-1, HBD-2 and cathelicidin LL-37,
three of the main human antimicrobial peptides. The
results demonstrated that 100 μg/ml HNP-1 and
100 μg/ml HBD-2 did not reduce the bacterial count for
the 3 isogenic morphotypes of any of the B. pseudomal-
lei isolates when compared with the initial inocula and
untreated controls.
In a pilot experiment with a range of LL-37 concen-
trations and exposure times, we found that LL-37
reduced the B. pseudomallei count at a concentration of
6.25 μM at 6 h. This condition killed 100% of a starting
inoculum of 4.6 × 106 CFU/ml E. coli control and
caused a 75.7 to 99.8% reduction of B. pseudomallei for
different isolates. A difference in bacterial survival was
observed between the three isogenic morphotypes (P <
0.001). Survival of type I was 1.5 (95%CI 1.1-2.2, P =
0.02) times higher than that for type II, but was 3.7
(95%CI 2.6-5.3, P < 0.001) times lower than that for
type III (Figure 2B).
Growth in low oxygen concentrations
Low oxygen concentration may limit the intracellular
growth of aerobic bacteria within the host [14]. We
examined the survival of 3 isogenic morphotypes and
determined whether morphotype switching occurred in
response to different oxygen concentrations during
incubation on Ashdown agar at 37°C. B. pseudomallei
survived in 5-15% oxygen concentration for 14 days,
with an average colony count of 95% (range 72-109%
for different isolates and morphotypes) compared to
control plates incubated in air for 4 days (Table 1).
There was no difference in the survival pattern
between 3 isogenic morphotypes (P > 0.10). B. pseudo-
mallei colonies were not visible on Ashdown agar after
incubation in an anaerobic chamber for 2 weeks. The
capability to recover from anaerobic conditions was
observed as colonies were visible at 48 h after reincu-
bation at 37°C in air, and colony counts were per-
formed after incubation for 4 days. The percentage of
bacteria recovered was not different between three
morphotypes (P > 0.10).
Effect of laboratory conditions on morphotype switching
Types I and II did not demonstrate colony morphology
variation over time in any of the conditions tested. Fig-
ure 3 shows the effect of various testing conditions of
type III for all 5 isolates. Between 1% and 13% of colo-
nies subcultured from 28 h TSB culture onto Ashdown
agar switched to alternative types. The switching of type
III appeared to be important for replication in macro-
phages. Following uptake, switching of type III increased
over time such that by the 8 h time point, between 48-
99% of the agar plate colonies (the range representing
differences between isolates) had switched to type I (iso-
lates K96243, 164, B3 and B4) or to type II (isolate 153).
Morphotype switching did not increase in acid, acidified
sodium nitrite, or LL-37. In contrast, morphotype
switching from broth culture containing 62.5 μM H2O2
increased over time of incubation, ranging between
24-49% of the plate colonies for different isolates. Inter-
estingly, between 15-100% of the total type III colony
count switched to an alternative morphotype after
recovery from anaerobic conditions. The pattern of
morphotype switching in all conditions tested was speci-
fic to isolates, with four isolates switching from type III
to type I (K96243, 164, B3 and B4), and one isolate
switching to II (153).
Discussion
Our previous paper reported a process of B. pseudomal-
lei colony morphology switching that occurred during
human melioidosis, and in an animal model, mouse
macrophage cell line J774A.1, human lung epithelial cell
line A549, and under starvation conditions in vitro. In
this study, we investigated whether the variable pheno-
type associated with different morphotypes resulted in a
survival fitness or disadvantage during interactions with
a human macrophage cell line U937 and after exposure
to factors that simulate the macrophage milieu.
Although our previous report described 7 different mor-
photypes from clinical isolates, the five isolates used
here from 3 different clinical and 2 environmental sam-
ples were only observed to switch under nutritional lim-
itation from parental type I to types II and III, allowing
comparison of 3 isogenic morphotypes with known vari-
able phenotype.
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The initial interaction between the human macrophage
cell line U937 and 3 isogenic morphotypes of B. pseudo-
mallei was not different between the three types. Despite a
comparable rate of extracellular growth between isogenic
morphotypes, heterogeneity in subsequent intracellular
survival/growth after this time point was observed.
Type III of each isolate was inconsistently capable of
multiplication after uptake by human macrophages, and
was associated with a change in morphotype. This sug-
gests that type III has a fitness disadvantage under these
circumstances. A possible explanation for this is that type
III does not appear to produce biofilm [11]. A biofilm
mutant demonstrated a mark reduction in intracellular
survival in primary human macrophages than the wild
Table 1 Growth and morphotype switching of 3 isogenic morphotypes derived from 5 B. pseudomallei isolates
following incubation in low oxygen and anaerobic conditions
Atmospheric conditions during incubation at 37°C
Starting
type
Air for 4 days (control) 5-15% oxygen for 14 days Reincubated in air for 4 days following
anaerobic conditions for 14 days
Mean colony
count,
(range)
*Morphotype,
% (range)
Mean % colony count
compared with control in air
(range)
*Morphotype,
% (range)
Mean % colony count
compared to control in air
(range)
*Morphotype,
% (range)
I (parental) 101
(93-106)
I 100% 92%
(78-108%)
I 100% 86%
(57-138%)
I 100%
II 90
(62-150)
II 100% 91%
(72-109%)
II 100% 95%
(66-127%)
II 100%
III 123
(110-141)
III 89%
(81-98%)
98%
(78-107%)
III 89%
(81-99%)
80%
(48-94%)
III 17%
(0-85%)
I or
II
11%
(2-19%)
I or II 11%
(1-19%)
I or
II
83%
(15-100%)
The data represents the mean of 5 B. pseudomallei isolates for each morphotype. The range reflected variation of % colony count between isolates. *%
Morphotype was the proportion of each morphotype on the plate. Morphotype switching was observed for type III (starting type) to either type I (isolates
K96243, 164, B3 and B4) or to type II (isolate 153).
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Figure 3 Effect of seven conditions on morphotype switching of type III of 5 B. pseudomallei isolates. (i) TSB culture in air with shaking
for 28 h; (ii) intracellular replication in macrophages for 8 h; (iii) exposure to 62.5 μM H2O2 in LB broth for 24 h; (iv) growth in LB broth pH 4.5
for 24 h; (v) exposure to 2 mM NaNO2 in LB broth for 6 h; (vi) exposure to 6.25 μM LL-37 in 1 mM potassium phosphate buffer (PPB) pH 7.4 for
6 h; and (vii) re-exposure to air after incubation in anaerobic chamber for 2 weeks. All experiments were performed using the experimental
details described above. B. pseudomallei morphotype on Ashdown agar following incubation in air at 37°C for 4 days was defined and compared
with the starting morphotype. Morphotype switching was presented as the proportion (%) of alternative types in relation to the total colonies
present.
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type, suggesting that biofilm production is associated with
the ability to survive in human macrophages [8].
Our previous study examined the survival and replica-
tion of B. pseudomallei strain 153 in the human respira-
tory epithelial cell line A549 and the mouse macrophage
cell line J744A.1. Our finding here that type III of strain
153 had increased survival in the human macrophage
cell line U937 is consistent with our previous findings
for the mouse macrophage cell line J774A.1 infected
with the same strain [11]. However, the use of a wider
number of strains in this study demonstrated that there
was a lack of reproducibility between strains. We sug-
gest that this is likely relate to variability in genomic
content between the strains tested. Future testing strate-
gies require the evaluation of a large numbers of strains
that have undergone whole genome sequencing to facili-
tate statistically robust comparisons between genomic
variation and phenotypic behaviour.
Several components of the innate immune system are
efficient in killing organisms within human macrophages
[15]. The most important of these are the antimicrobial
peptides and nitric oxide (NO), the superoxide anion
(O2
-), and hydrogen peroxide (H2O2), all of which are
directly toxic to bacteria. Reactive oxygen species gener-
ated by the phagocyte NADPH oxidase have an essential
role in the control of B. pseudomallei infection in
C57BL/6 bone marrow derived macrophages [16]. Type
I of all 5 B. pseudomallei isolates tested here had the
greatest resistance to H2O2, followed by types II and III,
respectively, suggesting that type I has the greatest
potential to scavenge or degrade H2O2 molecules. This
may explain the finding that type I had the highest
replication after uptake by the macrophage cell line.
Type III switched to type I or II during culture in med-
ium containing H2O2, indicated that type III had a survi-
val disadvantage under such conditions that required
switching to a more H2O2 resistant type.
One of the mechanisms by which B. pseudomallei
escapes macrophage killing is by repressing inducible
nitric oxide synthase (iNOS) by activating the expression
of two negative regulators, a suppressor of cytokine sig-
naling 3(SOC3) and cytokione-inducible src homology2-
containing protein (CIS) [17]. It is unknown whether
there are variation between strains and isogenic mor-
photypes in the ability to interfere with iNOS induction.
However, colony morphology differences did not influ-
ence resistance to RNI. B. pseudomallei is protected
from RNI by the production of alkyl hydroperoxide
reductase (AhpC) protein and depends on OxyR regula-
tor and a compensatory KatG expression [18]. These
mechanisms may not be associated with colony mor-
phology variability.
B. pseudomallei survive in the phagolysosome [10]
which are acidified environments containing lysozymes,
proteins and antimicrobial peptides that destroy patho-
gen. There was no difference in growth for the 3 iso-
genic morphotypes of B. pseudomallei derived from all
five isolates at all pH levels tested above 4.0, but a pH
of 4.0 was universally bactericidal, suggesting that mor-
photype switching did not provide a survival advantage
against acid conditions.
All morphotypes of B. pseudomallei were highly resis-
tance to lysozyme and lactoferrin. Lysozyme functions
to dissolve cell walls of bacteria. Lactoferrin is a compe-
titor that works by binding iron and preventing uptake
by the bacteria. Common structures for resistance to
these factors such as capsule and LPS [8] were present
in all isogenic morphotypes [11]. An alternative explana-
tion is that B. pseudomallei may produce a morphotype-
independent lysozyme inhibitor that counteracts the
action of lysozyme and lactoferrin.
Antimicrobial peptides are efficient at killing a broad
range of organisms. They are distributed in variety tis-
sues, and in neutrophils and macrophages [12,13]. All 3
isogenic B. pseudomallei morphotypes were resistant to
a-defensin HNP-1 and b-defensin HBD-2, but were sus-
ceptible to LL-37. In contrast to sensitivity to H2O2,
type III was more resistant than type I or II to LL-37.
This ability may allow type III to survive within host
cells for a limited period before successfully switching to
alternative phenotypes and may provide a fitness of
advantage in macrophages.
Another feature of bacterial survival during the estab-
lishment of persistent infection in the host is adaptation
to hypoxia in the host microenvironment [14]. This
study demonstrated that all 3 isogenic morphotypes
were able to tolerate a low oxygen concentration and
anaerobic conditions for at least two weeks. Type III
switching to either type I or II was observed during
recovery from anaerobic incubation. The fact that types
I and II were stable following anaerobic incubation sug-
gests that they are tolerant of fluctuations in oxygen
concentration.
Given the variation in the genome of different B. pseu-
domallei, it was not surprising to observe some variation
in intracellular replication between isogenic morpho-
types of different isolates. Only one strain switched from
type III to II, while the other four isolates switched from
type III to type I in all conditions in which a change in
morphotype was observed. Analyses of 5 isolates in this
study provide evidence that colony morphology variation
represents heterogeneous phenotypes of B. pseudomallei
with different fitness advantages to interact, survive and
replicate in the presence of bactericidal substances
within human macrophages.
A limitation of this study is that the experimental
methods were laborious and time consuming, which
restricted the number of strains we could examine. It is
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also unclear whether these in vitro assays using a human
macrophage cell line are a good model for human infec-
tion. Further studies are required to determine the
molecular mechanism of morphotype switching, and
whether this is associated with persistence of B. pseudo-
mallei in the human host.
Conclusions
B. pseudomallei can produce different colony morpholo-
gies in vivo and in vitro. This study has described the
intracellular survival and replication of two isogenic
morphotypes II and III generated from 5 different par-
ental type I B. pseudomallei in the U937 human macro-
phage cell line, and has examined the survival of these
isogenic morphotypes compared to the parental types in
the presence of a variety of substances and under condi-
tions which are potentially encountered within the
macrophage milieu. Data for 5 isolates demonstrated
that there was variability in bacterial survival and repli-
cation following uptake by human macrophages between
parental type I and types II or III, as well as variability
between strains. Uptake of type III alone was associated
with colony morphology switching. Type I was asso-
ciated with survival in the presence of H2O2. In contrast,
isogenic morphotype III demonstrated higher resistance
to antimicrobial peptide LL-37. Specific morphotypes
were not associated with survival with susceptibility to
acid, acidified sodium nitrite, or resistance to lysozyme,
lactoferrin, HNP-1 or HBD-2. Incubation under anaero-
bic conditions was a strong driver for switching of type
III to an alternative morphotype in all isolates.
Methods
Bacterial isolates and isolation of isogenic morphotypes
Five B. pseudomallei isolates were examined in this
study. Isolates 153, 164 and the reference isolate
K96243 were cultured from cases of human melioido-
sis in Thailand, and isolates B3 and B4 were cultured
from uncultivated land in northeast Thailand [19]. The
colony morphology of all five parental isolates was
type I, and isogenic types II and III were generated
from type I of each strain using nutritional limitation
[11]. Briefly, a single colony of type I on Ashdown agar
was inoculated into 3 ml of TSB and incubated at 37°C
in air in static conditions for 21 days. Bacterial culture
was diluted and spread plated onto Ashdown agar.
Morphotypes were identified using a morphotyping
algorithm [11]. Isogenic types II and III generated
from each parental type I were isolated from the plates
of each strain.
Growth curve analysis
Growth curves were performed for the 3 isogenic mor-
photypes of each of the 5 B. pseudomallei isolates.
A colony of B. pseudomallei was suspended in sterile
phosphate buffered saline (PBS). The bacterial suspen-
sion was adjusted to an optical density (OD) at 600 nm
of 0.15 and diluted 100 times. One hundred microlitres
of bacterial suspension was added to 10 ml of TSB and
incubated at 37°C in air with shaking at 200 rpm for 28
h. At 2 h intervals, 100 μl of bacterial culture was
removed, serially diluted 10-fold in PBS, and the bacter-
ial count determined by plating on Ashdown agar in
duplicate and performing a colony count following incu-
bation at 37°C in air for 4 days. Doubling time was
calculated.
Cell line and culture conditions
Human monocyte-like cell line U937 (ATCC CRL-
1593.2) originating from a histiocytic lymphoma was
maintained in RPMI 1640 (Invitrogen) supplemented
with 10% heat-inactivated fetal bovine serum (PAA
Laboratories), 100 units/ml of penicillin and 100 μg/ml
of streptomycin (Invitrogen) and cultured at 37°C in a
5% CO2 humidified incubator [20]. Before exposure to
B. pseudomallei, 1 × 105 U937 cells per well were trans-
ferred to a 24 well-tissue culture plate (BD Falcon) and
activated by the addition of 50 ng/ml of phorbol 12-
myristate 13-acetate (PMA) (Sigma) over 2 days [20].
The medium was then replaced with 1 ml of fresh med-
ium without PMA and incubated for 1 day. The differ-
entiated macrophage was assessed by macrophage-like
morphology [21]. Following washing 3 times with 1 ml
of Hank’s balance salt solution (HBSS) (Sigma), 1 ml of
fresh medium was gently added to the macrophages.
Interaction of B. pseudomallei isogenic morphotypes with
human macrophages
The interaction assay was performed as previously
described [11]. B. pseudomallei from an overnight culture
on Ashdown agar was suspended in PBS, the bacterial
concentration adjusted using OD at 600 nm and then
diluted in PBS and inoculated into wells containing dif-
ferentiated U937 cells to obtain an MOI of approximately
25 bacteria per cell. The MOI was verified by colony
counting on Ashdown agar. Infected U937 cells were
incubated at 37°C in 5% CO2 for 2 h. Non-adherent bac-
teria were removed by washing gently 3 times with 1 ml
of PBS. The U937 cells were lysed with 1 ml of 0.1%
Triton X-100 (Sigma), and the cell lysates serially diluted
in PBS and spread plated on Ashdown agar to obtain the
bacterial count. Colony morphology was observed [11].
The percentage of bacteria that were cell-associated was
calculated by (number of associated bacteria × 100)/num-
ber of bacteria in the inoculum. The experiment was per-
formed in duplicate for 2 independent experiments.
Intracellular survival and multiplication of B. pseudo-
mallei in human macrophages were determined at a
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series of time points following the initial co-culture
described above of differentiated U937 with B. pseudo-
mallei for 2 h. Following removal of extracellular bac-
teria and washing 3 times with PBS, medium containing
250 μg/ml kanamycin (Invitrogen) was added and incu-
bated for a further 2 h (4 h time point). New medium
containing 20 μg/ml kanamycin was then added to inhi-
bit overgrowth by any remaining extracellular bacteria
at further time points. Intracellular bacteria were deter-
mined at 4, 6 and 8 h after initial inoculation. Infected
cells were washed, lysed and plated as above. Intracellu-
lar survival and multiplication of B. pseudomallei based
on counts from cell lysates were presented. Percent
intracellular bacteria was calculated by (number of intra-
cellular bacteria at 4 h) × 100/number of bacteria in the
inoculum. Percent intracellular replication was calcu-
lated by (number of intracellular bacteria at 6 or 8 h ×
100)/number of intracellular bacteria at 4 h. The experi-
ment was performed in duplicate for 2 independent
experiments.
Growth in acid conditions
B. pseudomallei from an overnight culture on Ashdown
agar was suspended in PBS and adjusted using OD at
600 nm to a concentration of 1 × 106 CFU/ml in PBS.
Thirty microlitres of bacterial suspension was inoculated
into 3 ml of Luria-Bertani (LB) broth at a pH 4.0, 4.5 or
5.0. The broth was adjusted to acid pH with HCl.
Growth in LB broth at pH 7.0 was used as a control.
The culture was incubated at 37°C in air with shaking at
200 rpm. At 1, 3, 6, 12 and 24 h time intervals, the cul-
ture was aliquoted and viability and growth determined
by serial dilution and plating on Ashdown agar.
Susceptibility of B. pseudomallei to reactive oxygen
intermediates (ROI)
The sensitivity of B. pseudomallei to reactive oxygen
intermediates was determined by growth on oxidant
agar plates and in broth containing H2O2. Assays on
agar plates were performed as described previously [22],
with some modifications. Briefly, an overnight culture of
B. pseudomallei harvested from Ashdown agar was sus-
pended in PBS and the bacterial concentration adjusted
using OD at 600 nm. A serial dilution of the inoculum
was spread plated onto Ashdown agar to confirm the
bacterial count and colony morphology. Ten microlitres
of serial dilutions of bacteria in PBS were spotted onto
LB agar containing 0, 170, 310, 625, 1,250 and 2,500 μM
H2O2. Colony counts were performed after incubation at
37°C in air for 24 h. The number of colonies on plates
containing H2O2 was compared with that on control
plates and presented as bacterial survival (%). The assay
was performed for 4 independent experiments.
Sensitivity to killing by hydrogen peroxide was further
examined in LB broth. An overnight culture of B. pseu-
domallei on Ashdown agar was suspended in PBS and
adjusted to approximately 1 × 108 CFU/ml. Ten microli-
tres of bacterial suspension was added into 1 ml of LB
broth containing two-fold decreasing concentrations of
H2O2 ranging from 500 to 31.25 μM. The mixtures
were statically incubated at 37°C in air for 24 h and
then the viable count and colony morphotype were
determined by serial dilution and plating on Ashdown
agar. The experiment was performed for 2 independent
experiments.
Susceptibility of B. pseudomallei to reactive nitrogen
intermediates (RNI)
B. pseudomallei from an overnight culture on Ashdown
agar was suspended in PBS and the bacterial concentra-
tion adjusted using OD at 600 nm. Thirty microlitres of
bacterial suspension was added into 3 ml of two-fold
decreasing concentrations of sodium nitrite (ranging
from 10 to 0.1 mM) in LB broth at pH 5.0. The mixture
was incubated at 37°C in air with shaking at 200 rpm
and viable bacteria were determined at 6 h by serial
dilution and plating on Ashdown agar. The number of
viable bacteria in the presence of NaNO2 was compared
with the number of bacteria in the inoculum and pre-
sented as bacterial survival (%). The experiment was
performed in duplicate for 2 independent experiments.
Susceptibility of B. pseudomallei to lysozyme and
lactoferrin
B. pseudomallei cultured overnight on Ashdown agar
was harvested and suspended in 10 mM Tris-HCl buffer
pH 5.0 [23]. The bacterial suspension was adjusted to a
concentration of 1 × 107 CFU/ml. Fifty microlitres of
bacterial suspension was added to an equal volume of
400 μg/ml chicken egg white lysozyme (48,000 U/mg
protein) (Sigma) to obtain a final concentration of
200 μg/ml. The mixture was incubated at 37°C in air for
24 h, after which 10 μl of 10-fold serial dilutions were
dropped on Ashdown agar. Sensitivity to lysozyme was
also tested in the presence of 3 mg/ml lactoferrin
(Sigma) in a separate experiment [23]. E. coli strain
HB101 was tested in parallel as a control.
Susceptibility to human a-defensin and b-defensin
B. pseudomallei was tested for resistance to HNP-1 and
HBD-2 (Peptide international) as described previously
[24], with the exception that HNP-1 was used at twice
the dose. E. coli strain HB101 was tested in parallel as a
control. Briefly, B. pseudomallei or E. coli strain HB101
colonies were washed and suspended in 1 mM sodium
phosphate buffer pH 7.4 containing 1% TSB [24]. The
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bacterial suspension was adjusted to a concentration of
1 × 107 CFU/ml. Twenty microlitres of bacterial suspen-
sion was mixed with an equal volume of 200 μg/ml
HNP-1 or HBD-2 to obtain a final concentration of
100 μg/ml antimicrobial peptide and incubated at 37°C
in air for 3 h. The viable bacterial count was determined
by dropping a 10-fold serial dilution on Ashdown agar.
Susceptibility to antimicrobial activity of human
cathelicidin
B. pseudomallei susceptibility to cathelicidin LL-37 was
tested using a microdilution method [25]. LL-37 was
kindly provided by Dr. Suwimol Taweechaisupapong,
Department of Oral Diagnosis, Faculty of Dentistry,
Khon Kaen University and Dr. Jan G.M. Bolscher,
Department of Oral Biochemistry, Van der Boechorst-
straat, Amsterdam, The Netherlands. A loop of bacteria
was washed 3 times in 1 mM potassium phosphate buf-
fer (PPB) pH 7.4 and suspended in the same buffer. The
bacterial suspension was adjusted to a concentration of
1 × 107 CFU/ml. Fifty microlitres of suspension was
added into wells containing 50 μl of a 2-fold serial dilu-
tion of human cathelicidin in PPB (to obtain a final con-
centration of 3.125-100 μM), The mixture was incubated
at 37°C in air for 6 h and viability of bacteria was deter-
mined by plating a 10-fold serial dilution on Ashdown
agar. The assay was performed in duplicate.
Growth in low oxygen and anaerobic conditions
An overnight culture of B. pseudomallei on Ashdown
agar was suspended in PBS and adjusted to a concentra-
tion of 1 × 108 CFU/ml. The bacterial suspension was
10-fold serially diluted and 100 μl spread plated on Ash-
down agar to obtain approximately 100 colonies per
plate. Three sets of plates were prepared per isolate and
incubated separately at 37°C in 3 conditions: (i) in air for
4 days (control); (ii) in an GasPak EZ Campy Pouch Sys-
tem to produce an atmosphere containing approximately
5-15% oxygen (BD) for 2 weeks; or (iii) in an anaerobic
jar (Oxoid) with an O2 absorber (AnaeroPack; MGC) for
2 weeks and then re-exposed to air at 37°C for 4 days.
The mean colony count was determined for each mor-
photype from 5 B. pseudomallei isolates after incubating
bacteria in air for 4 days (control). % colony count for
each isolate incubated in 5-15% oxygen or in an anaero-
bic jar for 14 days was calculated in relation to the colony
count of the control incubating bacteria in air for 4 days.
Colony morphology switching
Seven conditions were observed for an effect on mor-
photype switching, as follows: (i) culture in TSB in air
with shaking for 28 h, (ii) intracellular growth in macro-
phage cell line for 8 h, (iii) exposure to 62.5 μM H2O2
in LB broth for 24 h, (iv) growth in LB broth at pH 4.5
for 24 h, (v) exposure to 2 mM NaNO2 for 6 h, (vi)
6.25 μM LL-37 for 6 h, and (vii) incubation in anaerobic
condition for 2 weeks and then re-exposure to air for
4 days. All experiments were performed using the
experimental details described above. B. pseudomallei
morphotype on Ashdown agar following incubation in
air at 37°C for 4 days was defined and compared with
the starting morphotype. Morphotype switching was
presented as the proportion (%) of alternative types in
relation to the total colonies present. Assays of resis-
tance to HNP-1, HBD-2, lysozyme and lactoferrin
employed a drop method to assess bacterial survival and
colony morphology could not be accurately determined.
Statistical analysis
Statistical analysis was performed using the statistical
program STATA version 10.1. Log transformation of
continuous dependent variables was performed as
appropriate. Nested repeated measures ANOVA was
used to test continuous dependent variables between 3
isogenic morphotypes. A difference between 3 morpho-
types was considered to be statistically significant when
the P value was less than or equal to 0.05, after which
pairwise comparisons were performed between each
morphotype. All P values for pairwise analyses were cor-
rected using the Benjamini-Hochberg method for multi-
ple comparisons [26].
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